130064-20-9

Upstream product

• 110-87-2 3,4-dihydro-2H-pyran 
• 3669-41-8 1-(2,4-dihydroxyphenyl)-2-phenylethanone 
• 108-46-3 recorcinol 
• 103-82-2 phenylacetic acid 

Downstream Products

• 130064-32-3 1-(2-{4-[3-Phenyl-7-(tetrahydro-pyran-2-yloxy)-2H-chromen-2-yl]-phenoxy}-ethyl)-piperidine 
• 130064-33-4 2-<4-(2-piperidinoethoxy)phenyl>-3-phenyl-7-hydroxy-2H-1-benzopyran 
• 130064-31-2 2-(4-hydroxyphenyl)-3-phenyl-7-<(tetrahydropyran-2-yl)oxy>-2H-1-benzopyran 
• 18435-79-5 trans-7-hydroxy-2,3-diphenyl-2,3-dihydro-4H-1-benzopyran-4-one 
• 130064-25-4 1-<2-hydroxy-4-<(tetrahydropyran-2-yl)oxy>phenyl>-2-phenyl-3-(4-hydroxyphenyl)prop-2-en-1-one 
• 130064-24-3 2-(4-hydroxyphenyl)-3-phenyl-7-<(tetrahydropyran-2-yl)oxy>-2,3-dihydro-4H-1-benzopyran-4-one 

Relevant academic research and scientific papers

ANTI-ESTROGENIC COMPOUNDS

The present disclosure provides a compound of Formula I: or a pharmaceutically acceptable salt wherein X, R1-R8, Y1-Y5, m, n, p, and q are defined herein. The novel 2H-chromene compounds are useful for the modul

Structure-Activity Relationship of Antiestrogens. Phenolic Analogues of 2,3-Diaryl-2H-1-benzopyrans

Phenolic analogues of 2--3-phenyl-2H-1-benzopyran (1), a novel antiestrogen, were synthesized and evaluated for their structure-activity relationship.Incorporation of OH at position 7 was found to improve receptor affinity of